HIGHLIGHTS
- who: Ruth L. Goodall from the (UNIVERSITY) have published the paper: Keeping up with the guidelines: design changes to the STREAM stage 2 randomised controlled non-inferiority trial for rifampicin-resistant tuberculosis, in the Journal: (JOURNAL) of 10/02/2016
- what: The sample size was therefore reduced, and the trial aimed to enrol 200 participants each to regimens B and C, which allows for up to 14% of participants excluded from the efficacy analysis in the per-protocol population. The trial currently has one primary objective, to assess whether the proportion of participants with a . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.